Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
CSO & EVP, Head of Research
-
Stock Symbol
-
ALNY on Nasdaq
Kevin Fitzgerald - trading volume in the past year for Alnylam Pharmaceuticals, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
12.9K |
$3.54M |
$274.65 |
Aug 12, 2024 |
Direct |
|
|
| Common Stock |
537 |
$147K |
$274.65 |
Aug 12, 2024 |
by Managed Account |
|
|
| Stock Option (right to buy) |
0 |
|
|
Aug 12, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.